CVS Health Enterprise Value over EBITDA Trend

CVS Health Corporation -- USA Stock  

USD 70.68  0.42  0.6%

This module enables investors to look at CVS Health various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Consolidated Income of 5.6 B, Cost of Revenue of 145 B or Earning Before Interest and Taxes EBIT of 10.1 B, but also many exotic indicators such as Interest Coverage of 11.0805, Long Term Debt to Equity of 0.7377 or Calculated Tax Rate of 40.8966. This module is a perfect complement to use when analyzing CVS Health Valuation or Volatility. It can also complement various CVS Health Technical models. Check also analysis of CVS Health Correlation with competitors.
Showing smoothed Enterprise Value over EBITDA of CVS Health Corporation with missing and latest data points interpolated. Measures the ratio between Enterprise Value and Earnings Before Interest Taxes and Depreciation Amortization USD.
Enterprise Value over EBITDA  10 Years Trend  
Increasing
Slightly volatile
 Enterprise Value over EBITDA 
      Timeline 

CVS Health Enterprise Value over EBITDA Over Time

2015-12-31  11.48 
2016-12-31  8.93 
2017-12-31  10.74 

Other Fundumenentals

 

Regression Statistics

Arithmetic Mean  9.07
Geometric Mean  8.88
Coefficient Of Variation  21.49
Mean Deviation  1.68
Median  8.93
Standard Deviation  1.95
Sample Variance  3.8
Range  5.07
R Value  0.45
Mean Square Error  3.34
R Squared  0.2
Significance  0.14
Slope  0.24
Total Sum of Squares  41.79

Currently Trending

V   
 NYQ 
Purchased over 20 shares of
1 hour ago ago
Traded for 109.82
GM   
 NYQ 
Purchased over 70 shares of
1 hour ago ago
Traded for 43.88
VMW   
 NYQ 
Purchased over 20 shares of
1 hour ago ago
Traded for 123.26